Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT03812432
Other study ID # XMOL16012019
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date January 15, 2019
Est. completion date December 31, 2019

Study information

Verified date January 2019
Source Hospital Son Espases
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The objective of this clinical trial is to visualize the bile ducts by injecting a contrast that is only visible with infrared light. For this, a quantity of bile will be extracted from the gallbladder by puncture and the same amount of contrast will be introduced.

During the intervention teh tissue wil be exposure to infrared light to visualize the bile ducts. This technique aims to increase safety in surgery to avoid damaging bile or vascular structures during gallbladder interventions.


Description:

Laparoscopic cholecystectomy is one of the most commonly performed procedures in adult surgery. A rare but serious complication of laparoscopic cholecystectomy is bile duct injury, with a reported incidence of 0.3-1.5 %. Bile duct injury is often caused by misinterpretation of the anatomical structures rather than by insufficient technical skills. Generally, bile duct injury leads to bile leakage, causing abdominal sepsis. It can also lead to obstruction, with obstructive jaundice, eventually potentially leading to a need for liver transplantation in the worst case. Late recognition is common in bile duct injuries, resulting in significant morbidity and mortality, a lower quality of life and extra costs. A recent expert consensus report identified establishment of the critical view of safety as the single most important factor for overall safety during laparoscopic cholecystectomy. However, evidence suggests that surgeons may actually achieve this view far less often than they believe.

Numerous intraoperative visualization techniques and technologies have been developed to enhance the safety of laparoscopic cholecystectomy. There are mainly two intraoperative imaging techniques to consider: first, the historical X-ray-based intraoperative cholangiography, and secondly the emerging fluorescence-based intraoperative near-infrared cholangiography. Large retrospective and prospective studies have looked at the benefit of routine intraoperative radiographic cholangiography for detection of common bile duct stones and to identify or prevent bile duct injury. Whether this procedure should be performed routinely is still an active subject of debate as systematic reviews are inconclusive; however, several of the larger retrospective studies observed a decrease in frequency and severity of bile duct injury when intraoperative cholangiography is performed. Limiting factors for performing radiographic laparoscopic cholangiography include: it requires specific expertise in the technique and its interpretation; it involves the use of ionizing radiation; it is time-consuming; and it creates a risk for bile leakage and duct injury itself, since puncturing and cannulation of the cystic duct is required. These limitations justify the quest for alternative, less complicated techniques to visualize biliary anatomy during cholecystectomy. Fluorescence-based intraoperative near-infrared cholangiography during laparoscopic cholecystectomy has been introduced by Ishizawa et al. in recent years as a non-invasive, radiation-free, low-cost alternative for realtime visualization of the biliary anatomy. This technique requires near-infrared laparoscopic imaging systems, as well as the intravenous injection of a fluorophore, i.e., indocyanine green, which is eliminated through the biliary tree. Following exposure to the near-infrared fluorescenc light source, indocyanine green becomes fluorescent and highlights relevant biliary structures. Since the pioneer studies, a large number of trials have been conducted and several protocols are currently underway, in order to establish the clinical efficacy of near-infrared cholangiography. A recent systematic review of clinical studies on near-infrared cholangiography has reported high visualization rates of biliary structures, as a surrogate marker of clinical efficacy, before dissection of Calot's triangle. However, one of the most significant drawbacks of near-infrared cholangiography following systemic indocyanine green injection lies in the very high background signal due to the rapid accumulation of indocyanine green in the liver, which can impair the visualization of the biliary structures.

One of the strategies to improve the visualization of the cystic duct and the common bile duct, without suffering from the disturbing background liver enhancement, is to perform a near-infrared cholecystocholangiography, by injecting the fluorophore directly into the gallbladder, as previously demonstrated in a porcine experimental study.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 80
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years to 90 Years
Eligibility Inclusion Criteria:

1. Scheduled for elective laparoscopic cholecystectomy.

2. Normal liver and renal function.

3. No hypersensitivity for iodine or indocianine green.

4. Able to understand nature of the study procedures.

5. Willing to participate and with written informed consent.

Exclusion Criteria:

1. Age < 18 years.

2. Liver or renal insufficiency.

3. Known iodine or indocianine green hypersensitivity.

4. Pregnancy or breastfeeding.

5. Not able to understand nature of the study procedure.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Near-infrared fluorescence cholecystocholangiography
Device: Real-Time Fluorescence Imaging (VISERA ELITE II Imaging System). These device is used to identify anatomy, using infrared light that causes the indocianine green to fluoresce.

Locations

Country Name City State
Spain Hospital Universitario Son Espases Palma de Mallorca Baleares

Sponsors (1)

Lead Sponsor Collaborator
Hospital Son Espases

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Visualization of the cystic duct, common hepatic duct, common bile duct and cysticocholedochal junction. Percentage of patients for whom fluorescence allows visualize cystic duct, common hepatic duct, common bile duct and cysticocholedochal junction with precision. cysticocholedochal junction. Intra-operatively
See also
  Status Clinical Trial Phase
Completed NCT04852016 - Optimizing the Consent Process for Emergent Laparoscopic Cholecystectomy N/A
Withdrawn NCT00979186 - A Trial to Evaluate Natural Orifice Transgastric Endoscopic Cholecystectomy With Laparoscopic Assistance N/A
Recruiting NCT06058195 - Comparison of Quadratus Lumborum and Transverse Abdominis Plane Blocks With Intravenous Analgesic in Gallbladder Surgery
Enrolling by invitation NCT02983474 - Korea Surgical Quality Improvement Program N/A
Recruiting NCT05089526 - Opioid-free Anesthesia in Laparoscopic Cholecystectomies N/A
Completed NCT04300985 - Magnesium Sulfate Versus Dexmedetomidine on Anesthesia Awakening. Phase 3
Recruiting NCT03817541 - Expiratory and Plasma Propofol Concentration in Gastrological Surgery Patients N/A
Completed NCT03577873 - RCT on Necessity of Cholecystectomy for Patients After Clearance of Bile Duct Stones N/A
Completed NCT04270357 - Surgical Practices in Algeria : the Cholecystectomy
Completed NCT00689663 - Laparoscopic Cholecystectomy - Fundus First and Harmonic Ace Compared With Conventional Technique N/A
Recruiting NCT06447545 - Comparison Between Low Pressure Pneumoperitoneum With High Pressure Pneumoperitoneum in Post-operative Pain, Shoulder Tip Pain and Common Bile Duct Injuries in Patients Undergoing Laparoscopic Cholecystectomy N/A
Completed NCT03510923 - Selective Rather Than Routine Histopathological Examination Following Appendectomy and Cholecystectomy
Completed NCT03329859 - Microcomplications in Lap. Cholecystectomy: Reducing Intraoperative Interruptions by High Resolution Standardization N/A
Terminated NCT02163239 - Post Market Study for FloShield 10mm Reusable Cannula and Blunt Obturator and Robotic FloShield N/A
Completed NCT02085902 - Does the Use of Ropivacaine Facilitates Cholecystectomy by Laparoscopy in Ambulatory Surgery? Phase 4
Completed NCT06468735 - The Relationship Among Sarcopenia, Preperitoneal Fat Thickness and Cholecystectomy N/A
Completed NCT05681338 - Effect of the Coughing Technique During Subcutaneous Heparin Injection N/A
Completed NCT06020768 - The Effect of Different Bed-Head Angles on the Haemodynamic Parameters of Intensive Care Patients Lying in the Supine Position N/A
Completed NCT01211743 - Oxidative Stress in Standard Laparoscopic vs Single Port Cholecystectomy Phase 4
Completed NCT06028061 - Evaluation of Effectivity of Quadratus Lumborum Blocks With Adjuvant N/A